Replies to post #137232 on WEALTH UNIVERSITY

[10bags]

yes also had news today:

VANCOUVER, Nov. 4, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that the U.S. Food and Drug Administration (FDA) will hold a Cardiovascular and Renal Drugs Advisory Committee (CRDAC) meeting in connection with its review of the pending New Drug Application (NDA) for Brinavess™ (vernakalant hydrochloride, IV). The meeting will be held on December 10, 2019 from 8:00 a.m. to 5:00 p.m. ET. The proposed indication to be discussed at this upcoming CRDAC meeting is for the rapid conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adult patients.

https://ih.advfn.com/stock-market/NASDAQ/correvio-pharma-CORV/stock-news/81057068/correvio-announces-fda-advisory-committee-meeting